CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
Accelerated intermittent theta-burst treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03953417
NCT03953417N/ACompleted
CompareCT.gov

Pilot Accelerated Theta Burst Stimulation in Treatment-Resistant Bipolar Depression

Stanford University·interventional·Posted May 16, 2019·Updated Feb 4, 2026

In Brief

A clinical study evaluating Accelerated intermittent theta-burst treatment for Treatment Resistant Depression. Completed, enrolled 7 participants across 1 site.

Detailed Summary

This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for treatment-resistant bipolar depression. In this open-label study, all participants will receive accelerated theta-burst stimulation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment Resistant Depression
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 16, 2019
Enrollment StartJul 1, 2019
Primary CompletionDec 30, 2023
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 7.1 years ago

Interventions

Accelerated intermittent theta-burst treatmentdevice

All participants will receive accelerated intermittent theta-burst stimulation to the left DLPFC. Treatment will be targeted by utilizing the Localite neuronavigation system. Stimulation intensity will be standardized at 90% of resting motor threshold adjust to the skull to cortical surface distance. Stimulation will be delivered to left DLPFC using the MagPRo stimulator.